Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of laboratory tests
3.2.1.2 Rising usage of lab tests for precise disease diagnosis
3.2.1.3 Growing R&D activities and technological advancements in sample collection techniques
3.2.1.4 Expansion of biobanking and personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced kits and complexities associated with specimen collection
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Future market trends
3.7 Value chain analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Swabs
5.2.1 Nasopharyngeal (NP) swabs
5.2.2 Oropharyngeal (OP) swabs
5.2.3 Nasal swabs
5.3 Viral transport media
5.4 Blood collection kits
5.5 Urine collection kits
5.6 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Diagnostics
6.3 Research
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals and clinics
7.3 Diagnostic centers
7.4 Homecare
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Altona Diagnostics GmbH
9.3 Becton, Dickinson and Company
9.4 CTK Biotech, Inc.
9.5 F. Hoffmann-La Roche Ltd
9.6 Hardy Diagnostics
9.7 HiMedia Laboratories
9.8 Laboratory Corporation of America Holdings
9.9 Lucence Health Inc.
9.10 Medline Industries, Inc.
9.11 Miraclean Technology Co. Ltd
9.12 QIAGEN
9.13 Seegene Inc.
9.14 Thermo Fisher Scientific, Inc.
9.15 VIRCELL S.L.
